BriaCell Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
BriaCell Therapeutics Depreciation & Amortization Growth & History (BCTX)
BriaCell Therapeutics's depreciation and amortization was $106,627 for fiscal 2025.
View full BriaCell Therapeutics company overviewBriaCell Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-07-31 | $106,627 | $22,730 | +27.09% |
| 2024 | 2024-07-31 | $83,897 | $68,626 | +449.39% |
| 2023 | 2023-07-31 | $15,271 | −$1 | −0.01% |
| 2022 | 2022-07-31 | $15,272 | $16 | +0.10% |
| 2021 | 2021-07-31 | $15,256 | $1 | +0.01% |
| 2020 | 2020-07-31 | $15,255 | — | — |
BriaCell Therapeutics quarterly depreciation and amortization
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-04-30 | $29,193 | $2,537 | +9.52% |
| Q2 2026 | 2026-01-31 | $22,839 | $0 | 0.00% |
| Q1 2026 | 2025-10-31 | $22,839 | $0 | 0.00% |
| Q3 2025 | 2025-04-30 | $26,656 | $22,840 | +598.53% |
| Q2 2025 | 2025-01-31 | $22,839 | $19,020 | +498.04% |
| Q1 2025 | 2024-10-31 | $22,839 | $19,021 | +498.19% |
| Q3 2024 | 2024-04-30 | $3,816 | −$2 | −0.05% |
| Q2 2024 | 2024-01-31 | $3,819 | $2 | +0.05% |
| Q1 2024 | 2023-10-31 | $3,818 | $0 | 0.00% |
| Q3 2023 | 2023-04-30 | $3,818 | $1 | +0.03% |
| Q2 2023 | 2023-01-31 | $3,817 | −$2 | −0.05% |
| Q1 2023 | 2022-10-31 | $3,818 | $1 | +0.03% |
| Q3 2022 | 2022-04-30 | $3,817 | $3 | +0.08% |
| Q2 2022 | 2022-01-31 | $3,819 | — | — |
| Q1 2022 | 2021-10-31 | $3,817 | — | — |
| Q3 2021 | 2021-04-30 | $3,814 | — | — |
BriaCell Therapeutics depreciation and amortization trends
Over the last five fiscal years, BriaCell Therapeutics's depreciation and amortization increased from $15,255 to $106,627, a change of $91,372. The latest reported quarter, Q3 2026, shows $29,193.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BriaCell Therapeutics source filings ↗